Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Drug and Alcohol Dependence

• Publication date

  1986-06-01

• Fields of study

  Law, Medicine, Psychology

• Identifiers
  DOI 10.1016/0376-8716(86)90007-4PMID 2874968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A gas chromatographic study of the metabolism of tarugan.

  1973cited by this paper
• Metabolism and excretion of diethylpropion in man under acidic urine conditions

  1973cited by this paper
• [Therapy of patients with refrectory obesity].

  1972cited by this paper
• Excretion of amphetamines in human sweat.

  1972cited by this paper
• [Methamphetamine--a metabolite of the anorectics Benzphetamine and Furfenorex].

  1972cited by this paper
• Amphetamine concentrations in rat brain and human urine after fenproporex administration.

  1972cited by this paper
• The metabolic fate of 3H-fenetylline in man.

  1970cited by this paper
• [Metabolism of (+) N-methyl N-(furyl-2methyl) phenylisopropylamine cyclohexylsulfamate (furfenonex cyclohexylsulfamate) in rats].

  1968cited by this paper

• Neurobehavioral and molecular changes in rats exposed to either captagon or counterfeit captagon

  2025cites this paper
• Captagon: A comprehensive bibliometric analysis (1962–2024) of its global impact, health and mortality risks

  2024cites this paper
• An updated review on morpholine derivatives with their pharmacological actions

  2022cites this paper
• Vaccine-driven pharmacodynamic dissection and mitigation of Captagon psychoactivity

  2017cites this paper
• Fenethylline-Induced Psychosis, Fenethylline-Themed Paranoid Delusions, or Both?

  2017cites this paper
• Is Captagon (fenethylline) helping to fuel the Syrian conflict?

  2016cites this paper
• Fenethylline (Captagon) Abuse - Local Problems from an Old Drug Become Universal.

  2016cites this paper
• How ephedrine escaped regulation in the United States: a historical review of misuse and associated policy.

  2011cites this paper
• Chemical characterization of counterfeit captagon tablets seized in Jordan.

  2005cites this paper
• Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements.

  2004cites this paper
• Ephedrine-type alkaloid-containing dietary supplements and substance dependence.

  2003cites this paper
• Precursor Medications as a Source of Methamphetamine and/or Amphetamine Positive Drug Testing Results

  2002cites this paper
• Content versus label claims in ephedra-containing dietary supplements.

  2000cites this paper
• Fenethyllin psychosis: description of two cases.

  1999cites this paper
• Counterfeit Captagon: an analytical study

  1996cites this paper
• 18 – Substances of abuse

  1996cites this paper
• The characterization of counterfeit Captagon tablets

  1994cites this paper
• Clinical Features and Management of Intoxication Due to Hallucinogenic Drugs

  1989cites this paper
• Potentiation of cathinone by caffeine and nikethamide.

  1989cites this paper
• An epidemiological and clinical analysis of propylhexedrine abuse in the United States.

  1988cites this paper
• An epidemiological and clinical analysis of propylhexedrine abuse in the United States.

  1988cites this paper
• Epidemiologic issues pertinent to international regulation of 28 stimulant-hallucinogen drugs.

  1986cites this paper